María Georgina Oberto1, Elizabeth Liliana Asis2, María Daniela Defagó3. 1. Escuela de Nutrición de la Facultad de Ciencias Médicas de la Universidad Nacional de Córdoba. georginaoberto@hotmail.com. 2. Hospital Materno Neonatal "Ministro Ramón Carrillo" de Córdoba, Argentina. Carta . rosan60@hotmail.com. 3. Escuela de Nutrición, FCM-UNC e Instituto de Investigaciones en Ciencias de la Salud (INICSA CONICET). danieladefago@outlook.com.
Abstract
Introduction: continuous growth monitoring allows the identification of anthropometric and metabolic disorders as an integral part of HIV treatment. It was proposed to analyze the evolution of nutritional status, with the immunological and virological parameters in children infected with vertically transmitted HIV and its association with highly active antiretroviral treatment (HAART). Material and Methods: were included 56 children aged 0 to 12 years, attending the Hospital Materno Neonatal of Córdoba, Argentina between 1998-2014. Anthropometric and biochemical, immunological, virological nutritional status and clinical manifestations were evaluated by age group (younger or older than 6 years) and HAART administered in three medical controls. Results: in the third control the analysis of the anthropometric nutritional status according to the body mass index (BMI) diagnosed 47 children (83.93%) with a normal BMI and 6 (10.71%) overweight/obesity, without statistically significant difference by age group (p=0.10). Thirty six children (64.29%) presented hypertriglyceridemia, with higher concentrations at the second (p=0.003) and third control (p=0.06) in those treated with scheme II and III with protease inhibitors (PI), unlike scheme I without IP. Normoglycemia prevailed in 54 children (96.43%) and anemia in 29 (51.79%). The clinical manifestations decreased in the successive controls and in the last one, 3 children (5.36%) older than 6 years, had pneumonia and one (1.79%) severe immunosuppression. Conclusions: hypertriglyceridemia was the main adverse effect of the medication, which, added to the high prevalence of anemia, constitute important parameters for interdisciplinary treatment Universidad Nacional de Córdoba.
Introduction: continuous growth monitoring allows the identification of anthropometric and metabolic disorders as an integral part of HIV treatment. It was proposed to analyze the evolution of nutritional status, with the immunological and virological parameters in children infected with vertically transmitted HIV and its association with highly active antiretroviral treatment (HAART). Material and Methods: were included 56 children aged 0 to 12 years, attending the Hospital Materno Neonatal of Córdoba, Argentina between 1998-2014. Anthropometric and biochemical, immunological, virological nutritional status and clinical manifestations were evaluated by age group (younger or older than 6 years) and HAART administered in three medical controls. Results: in the third control the analysis of the anthropometric nutritional status according to the body mass index (BMI) diagnosed 47 children (83.93%) with a normal BMI and 6 (10.71%) overweight/obesity, without statistically significant difference by age group (p=0.10). Thirty six children (64.29%) presented hypertriglyceridemia, with higher concentrations at the second (p=0.003) and third control (p=0.06) in those treated with scheme II and III with protease inhibitors (PI), unlike scheme I without IP. Normoglycemia prevailed in 54 children (96.43%) and anemia in 29 (51.79%). The clinical manifestations decreased in the successive controls and in the last one, 3 children (5.36%) older than 6 years, had pneumonia and one (1.79%) severe immunosuppression. Conclusions: hypertriglyceridemia was the main adverse effect of the medication, which, added to the high prevalence of anemia, constitute important parameters for interdisciplinary treatment Universidad Nacional de Córdoba.
Entities:
Keywords:
nutritional status; anthropometry; child; HIV
Authors: Lígia Cardoso Dos Reis; Patrícia Helen de Carvalho Rondó; Heloisa Helena de Sousa Marques; Neuber José Segri Journal: Public Health Nutr Date: 2014-08-13 Impact factor: 4.022
Authors: T L Miller; B E Mawn; E J Orav; D Wilk; G A Weinberg; J Nicchitta; L Furuta; R Cutroni; K McIntosh; S K Burchett; S L Gorbach Journal: Pediatrics Date: 2001-05 Impact factor: 7.124
Authors: M Susana Rodríguez de Schiavi; Adriana Scrigni; Patricia García Arrigoni; Rosa Bologna; Graciela Barboni; Julia Redondo; Mariana Nastri; Débora Mecikovsky; Claudio Cantisano; Rina Moreno; Darío Siciliani; Mónica Lencina; Nora Luedicke; Gabriela Rezzónico; José L Torolla; Santiago López Papucci; Miguel Luis; Carmen Libonati; Luis Gamba; Jeanette Barbarysky; Ema Pérez Hernández; Rafael Zlatkes Journal: Arch Argent Pediatr Date: 2009-06 Impact factor: 0.635
Authors: G Krishna Swetha; R Hemalatha; U V Prasad; Vasudev Murali; K Damayanti; V Bhaskar Journal: Indian J Med Res Date: 2015-01 Impact factor: 2.375